Cargando…

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial

INTRODUCTION: A 60-cm endoscopically implantable duodenal–jejunal bypass liner (Endobarrier™, GI Dynamics, Lexington, MA, USA) has been introduced as a therapeutic option to support weight loss for a selected group of obese subjects with type 2 diabetes mellitus (T2DM). The sleeve prevents contact b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripolt, Norbert Joachim, Aberer, Felix, Url, Jasmin, Högenauer, Christoph, Schreiber, Florian, Eherer, Andreas, Sourij, Caren, Obermayer, Anna-Maria, Stadlbauer, Vanessa, Svehlikova, Eva, Brunner, Martina, Kojzar, Harald, Pferschy, Peter Nikolaus, Pieber, Thomas Rudolf, Sourij, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349299/ https://www.ncbi.nlm.nih.gov/pubmed/30539524 http://dx.doi.org/10.1007/s13300-018-0540-z

Ejemplares similares

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021)

INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022)

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
por: Obermayer, Anna, et al.
Publicado: (2023)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
por: Moser, Othmar, et al.
Publicado: (2020)

Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
por: Eckstein, Max L., et al.
Publicado: (2021)

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
por: Aberer, Felix, et al.
Publicado: (2019)

Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial
por: Moser, Othmar, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes—A Randomized Cross-Over Trial
por: Moser, Othmar, et al.
Publicado: (2019)

Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial
por: Moser, Othmar, et al.
Publicado: (2018)

Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
por: Tripolt, Norbert J., et al.
Publicado: (2023)

Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
por: Balint, Istvan Bence, et al.
Publicado: (2021)

Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study
por: Sourij, Caren, et al.
Publicado: (2022)

Albumin of People with Diabetes Mellitus Is More Reduced at Low HbA1c
por: Paar, Margret, et al.
Publicado: (2023)

Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects
por: Schweighofer, Natascha, et al.
Publicado: (2023)

Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination
por: Paar, Margret, et al.
Publicado: (2022)

Simplified Acute Physiology Score 3 Performance in Austrian COVID-19 Patients Admitted to Intensive Care Units with and without Diabetes
por: Aziz, Faisal, et al.
Publicado: (2022)

Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
por: Brunner, Martina, et al.
Publicado: (2022)

Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
por: Eyileten, Ceren, et al.
Publicado: (2022)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective
por: Aberer, Felix, et al.
Publicado: (2022)

Comment on: Davidson et al. High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis D. Diabetes Care 2013;36:260–266
por: Tripolt, Norbert J., et al.
Publicado: (2013)

The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial
por: Tripolt, Norbert J., et al.
Publicado: (2016)

A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
por: Moser, Othmar, et al.
Publicado: (2018)

Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial
por: Aberer, Felix, et al.
Publicado: (2018)

Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes
por: Tripolt, Norbert J, et al.
Publicado: (2014)

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
por: Sourij, Caren, et al.
Publicado: (2023)

Duodeno-Jejunal Varicosities Following Extrahepatic Portal Vein Thrombosis
por: Varsamidakis, Nick, et al.
Publicado: (1992)

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study
por: Stadlbauer, Vanessa, et al.
Publicado: (2015)

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
por: Aziz, Faisal, et al.
Publicado: (2023)

Gangliocytic paraganglioma leading to duodeno-jejunal intussusception: A case report
por: Fontana, Federico, et al.
Publicado: (2021)

Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study
por: Horvath, Angela, et al.
Publicado: (2019)

The Arrhythmogenic Face of COVID-19: Brugada ECG Pattern in SARS-CoV-2 Infection
por: Zimmermann, Paul, et al.
Publicado: (2022)

A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
por: Aberer, Felix, et al.
Publicado: (2021)

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
por: Benedikt, Martin, et al.
Publicado: (2023)

An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery
por: Narath, Sophie H., et al.
Publicado: (2016)

Duodeno-cholecystostomy
Publicado: (1889)

Cannot write session to /tmp/vufind_sessions/sess_4sfc93kgjenee1jt6bn5vpao8v